These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19375419)

  • 1. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance.
    Nakamura K; Aoyagi T; Hiroyama M; Kusakawa S; Mizutani R; Sanbe A; Yamauchi J; Kamohara M; Momose K; Tanoue A
    Eur J Pharmacol; 2009 Jun; 613(1-3):182-8. PubMed ID: 19375419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced glucose tolerance in the Brattleboro rat.
    Nakamura K; Yamashita T; Fujiki H; Aoyagi T; Yamauchi J; Mori T; Tanoue A
    Biochem Biophys Res Commun; 2011 Feb; 405(1):64-7. PubMed ID: 21215256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered lipid metabolism in vasopressin V1B receptor-deficient mice.
    Hiroyama M; Fujiwara Y; Nakamura K; Aoyagi T; Mizutani R; Sanbe A; Tasaki R; Tanoue A
    Eur J Pharmacol; 2009 Jan; 602(2-3):455-61. PubMed ID: 19068213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor.
    Aoyagi T; Kusakawa S; Sanbe A; Hiroyama M; Fujiwara Y; Yamauchi J; Tanoue A
    Eur J Pharmacol; 2009 Nov; 622(1-3):32-6. PubMed ID: 19766110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice.
    Aoyagi T; Birumachi J; Hiroyama M; Fujiwara Y; Sanbe A; Yamauchi J; Tanoue A
    Endocrinology; 2007 May; 148(5):2075-84. PubMed ID: 17303660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
    Winzell MS; Magnusson C; Ahrén B
    Metabolism; 2007 Jan; 56(1):122-8. PubMed ID: 17161234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
    J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor.
    Itoh S; Yamada S; Mori T; Miwa T; Tottori K; Uwahodo Y; Yamamura Y; Fukuda M; Yamamoto K; Tanoue A; Tsujimoto G
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E147-51. PubMed ID: 16464910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
    Coelho DF; Gualano B; Artioli GG; Roschel H; Amano M; Benatti FB; Fernandes T; Bueno CR; Câmara NO; Lancha AH
    Endocr Regul; 2009 Jul; 43(3):107-16. PubMed ID: 19817505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.
    Sainsbury A; Bergen HT; Boey D; Bamming D; Cooney GJ; Lin S; Couzens M; Stroth N; Lee NJ; Lindner D; Singewald N; Karl T; Duffy L; Enriquez R; Slack K; Sperk G; Herzog H
    Diabetes; 2006 Jan; 55(1):19-26. PubMed ID: 16380472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
    Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
    Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body water balance and body temperature in vasopressin V1b receptor knockout mice.
    Daikoku R; Kunitake T; Kato K; Tanoue A; Tsujimoto G; Kannan H
    Auton Neurosci; 2007 Oct; 136(1-2):58-62. PubMed ID: 17512263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet.
    Hwang B; Jeoung NH; Harris RA
    Biochem J; 2009 Sep; 423(2):243-52. PubMed ID: 19627255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
    Santos SH; Fernandes LR; Mario EG; Ferreira AV; Pôrto LC; Alvarez-Leite JI; Botion LM; Bader M; Alenina N; Santos RA
    Diabetes; 2008 Feb; 57(2):340-7. PubMed ID: 18025412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.
    Yazdi M; Ahnmark A; William-Olsson L; Snaith M; Turner N; Osla F; Wedin M; Asztély AK; Elmgren A; Bohlooly-Y M; Schreyer S; Lindén D
    Biochem Biophys Res Commun; 2008 May; 369(4):1065-70. PubMed ID: 18339309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
    Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
    Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.
    Hosooka T; Noguchi T; Kotani K; Nakamura T; Sakaue H; Inoue H; Ogawa W; Tobimatsu K; Takazawa K; Sakai M; Matsuki Y; Hiramatsu R; Yasuda T; Lazar MA; Yamanashi Y; Kasuga M
    Nat Med; 2008 Feb; 14(2):188-93. PubMed ID: 18204460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.